22157.jpg
Metastatic Colorectal Cancer Pipeline Insight Analysis 2024, Featuring Emerging Drugs Mirati Therapeutics Adagrasib, Qilu Pharmaceutical QL-1203 and Zentalis Pharmaceuticals ZN-c3
April 25, 2024 04:05 ET | Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Metastatic colorectal cancer - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides...
22157.jpg
Global Colorectal Cancer Pipeline Insights Report for 2024: An In-Depth Analysis of Clinical and Nonclinical Developments
April 23, 2024 07:28 ET | Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Colorectal Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The world is seeing an unprecedented increase...
22157.jpg
Colorectal Cancer Research Report 2023: Eight Major Market Drug Forecasts and Market Analysis 2021-2031
February 19, 2024 10:01 ET | Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Colorectal Cancer - Eight-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.Despite being a rare...
22157.jpg
Colorectal Cancer Diagnostics Market Research Report 2023: Rising Consumer Acceptance of Advanced Therapies Such as Stivarga (regorafenib), Erbitux (cetuximab), & Avastin (bevacizumab) Bolsters Growth
May 04, 2023 07:28 ET | Research and Markets
Dublin, May 04, 2023 (GLOBE NEWSWIRE) -- The "Colorectal Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Diagnosis Type, By...
FBI LOGO TM.png
With 4.3% CAGR, Colorectal Cancer Screening Market Size worth USD 22.88 Billion in 2029
October 31, 2022 05:59 ET | Fortune Business Insights
Pune, India, Oct. 31, 2022 (GLOBE NEWSWIRE) -- The colorectal cancer screening market size was valued at USD 14.32 billion in 2021. It is anticipated to touch USD 22.88 billion by 2029 at a CAGR of...
FBI LOGO TM.png
With 7.6% CAGR, Colorectal Cancer Therapeutics Market Size worth USD 16.58 Billion by 2026
August 22, 2022 08:54 ET | Fortune Business Insights
Pune, India, Aug. 22, 2022 (GLOBE NEWSWIRE) -- The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of...
ARC logo.png
Colorectal Cancer Treatment Market In North America Is Expected To Account For A Major Revenue Share During Forecast Period Till 2030: Acumen Research And Consulting
May 12, 2021 11:00 ET | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, has recently published a report titled “Colorectal Cancer Treatment Market – Global Industry Analysis, Market Size,...
22157.jpg
US Colorectal Cancer Market and Competitive Landscape 2021 - Pipeline Products, Market Analysis, Epidemiology, Key Products Marketed, Market Valuations & Forecast, Drugs Sales and Market Shares
January 22, 2021 05:43 ET | Research and Markets
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "US Colorectal Cancer Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This research report...
FBI LOGO TM.png
Colorectal Cancer Therapeutics Market to reach USD 16.58 billion by 2026, Presence of Strong Oncology Portfolio to help Players Gain Competitive: Reports Fortune Business Insights™
January 14, 2020 08:35 ET | Fortune Business Insights
Pune, Jan. 14, 2020 (GLOBE NEWSWIRE) -- The global Colorectal Cancer Therapeutics Market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal...